Skip to main content
Erschienen in: Wiener klinische Wochenschrift 13-14/2015

01.07.2015 | original article

Diagnostic and prognostic value of sCD14-ST—presepsin for patients admitted to hospital intensive care unit (ICU)

verfasst von: Matej Godnic, David Stubjar, Miha Skvarc, Tomislav Jukic

Erschienen in: Wiener klinische Wochenschrift | Ausgabe 13-14/2015

Einloggen, um Zugang zu erhalten

Abstract

Background

Sepsis is a serious problem in intensive care units all over the world. Biomarkers could be useful to identify patients at risk. We focused especially on the performance of presepsin (sCD14-ST), compared to C-reactive protein (CRP), procalcitonin (PCT) and CD64, to determine its diagnostic and prognostic indications.

Methods

The study was conducted on 47 hospitalized patients after procedures, who were divided into three groups; systemic inflammatory response (SIRS), sepsis and septic shock. Expression of CD64 on neutrophils presented as CD64 index, sCD14-ST, CRP and PCT were measured in whole blood or plasma samples. All patients had standard samples like urine, respiratory tract samples etc. taken for culturing. Blood cultures were drawn to confirm bloodstream infection.

Results

Forty (85 %) patients had SIRS with bacterial infection and seven (15 %) patients had SIRS with no infection. All infections were confirmed with blood cultures. Biomarkers were evaluated in all patients. In patients with confirmed infection the values were high. The patients with bacterial infection showed statistical significance with CD64 index (p = 0.003), CRP (p = 0.049) and sCD14-ST (p = 0.026), but not with PCT (p = 1.000). The severity of diagnosed SIRS was significant only with PCT (p < 0.001).

Conclusion

CD64 index, CRP and sCD14-ST served as good parameters to determine possible infection in patients that needed intensive care after major procedures. Values of PCT were the only ones to predict SIRS severity and could distinguish between sepsis and severe sepsis or septic shock.
Literatur
1.
Zurück zum Zitat Prashant A, Vishwanath P, Kulkarni P, Sathya Narayana P, Gowdara V, Nataraj SM, et al. Comparative assessment of cytokines and other inflammatory markers for the early diagnosis of neonatal sepsis—A case control study. PLoS One. 2013;8(7):e68426.doi: 10.1371/journal.pone.0068426.PubMedCentralPubMedCrossRef Prashant A, Vishwanath P, Kulkarni P, Sathya Narayana P, Gowdara V, Nataraj SM, et al. Comparative assessment of cytokines and other inflammatory markers for the early diagnosis of neonatal sepsis—A case control study. PLoS One. 2013;8(7):e68426.doi: 10.1371/journal.pone.0068426.PubMedCentralPubMedCrossRef
2.
Zurück zum Zitat Wong HR, Salisbury S, Xiao Q, Cvijanovich NZ, Hall M, Allen GL, et al. The pediatric sepsis biomarker risk model. Crit Care. 2012;16(5):R174. doi:10.1186/cc11652.PubMedCentralPubMedCrossRef Wong HR, Salisbury S, Xiao Q, Cvijanovich NZ, Hall M, Allen GL, et al. The pediatric sepsis biomarker risk model. Crit Care. 2012;16(5):R174. doi:10.1186/cc11652.PubMedCentralPubMedCrossRef
3.
Zurück zum Zitat Levy MM, Artigas A, Phillips GS, Rhodes A, Beale R, Osborn T, et al. Outcomes of the surviving sepsis campaign in intensive care units in the USA and Europe: a prospective cohort study. Lancet Infect Dis. 2012;12(12):919–24. doi:10.1016/S1473-3099(12)70239-6. Levy MM, Artigas A, Phillips GS, Rhodes A, Beale R, Osborn T, et al. Outcomes of the surviving sepsis campaign in intensive care units in the USA and Europe: a prospective cohort study. Lancet Infect Dis. 2012;12(12):919–24. doi:10.1016/S1473-3099(12)70239-6.
4.
Zurück zum Zitat Dellinger RP, Levy MM, Rhodes A, Annane D, Gerach H, Opal SM, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Intensive Care Med. 2013;39(2):165–228.PubMedCrossRef Dellinger RP, Levy MM, Rhodes A, Annane D, Gerach H, Opal SM, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Intensive Care Med. 2013;39(2):165–228.PubMedCrossRef
5.
Zurück zum Zitat Jordana-Lluch E, Carolan HE, Giménez M, Sampath R, Ecker DJ, Quesada MD, et al. Rapid diagnosis of bloodstream infections with PCR followed by mass spectrometry. PLoS One. 2013;23:8(4):e62108. doi: 10.1371. Jordana-Lluch E, Carolan HE, Giménez M, Sampath R, Ecker DJ, Quesada MD, et al. Rapid diagnosis of bloodstream infections with PCR followed by mass spectrometry. PLoS One. 2013;23:8(4):e62108. doi: 10.1371.
6.
Zurück zum Zitat Reinhart K, Bauer M, Riedemann NC, Hartog CS. New approaches to sepsis: molecular diagnostics and biomarkers. Clin Microbiol Rev. 2012;25:609–34.PubMedCentralPubMedCrossRef Reinhart K, Bauer M, Riedemann NC, Hartog CS. New approaches to sepsis: molecular diagnostics and biomarkers. Clin Microbiol Rev. 2012;25:609–34.PubMedCentralPubMedCrossRef
7.
Zurück zum Zitat Schuetz P, Maurer P, Punjabi V, Desai A, Amin DN, Gluck E. Procalcitonin decrease over 72 h in US critical care units predicts fatal outcome in sepsis patients. Crit Care. 2013;17(3):R115. doi:10.1186/cc12787.PubMedCentralPubMedCrossRef Schuetz P, Maurer P, Punjabi V, Desai A, Amin DN, Gluck E. Procalcitonin decrease over 72 h in US critical care units predicts fatal outcome in sepsis patients. Crit Care. 2013;17(3):R115. doi:10.1186/cc12787.PubMedCentralPubMedCrossRef
8.
Zurück zum Zitat Gebert S, Siegel D, Wellinghausen N. Rapid detection of pathogens in blood culture bottles by real-time PCR in conjunction with the pre-analytic tool MolYsis. J Infect. 2008;57(4):307–16.PubMedCrossRef Gebert S, Siegel D, Wellinghausen N. Rapid detection of pathogens in blood culture bottles by real-time PCR in conjunction with the pre-analytic tool MolYsis. J Infect. 2008;57(4):307–16.PubMedCrossRef
9.
Zurück zum Zitat Kopterides P, Tsangaris I. Procalcitonin and sepsis: recent data on diagnostic utility prognostic potential and therapeutic implications in critically ill patients. Minerva Anestesiol. 2012;78(7):823–35.PubMed Kopterides P, Tsangaris I. Procalcitonin and sepsis: recent data on diagnostic utility prognostic potential and therapeutic implications in critically ill patients. Minerva Anestesiol. 2012;78(7):823–35.PubMed
10.
Zurück zum Zitat Davis BH. Improved diagnostic approaches to infection/sepsis detection. Expert Rev Mol Diagn. 2005;5(2):193–207.PubMedCrossRef Davis BH. Improved diagnostic approaches to infection/sepsis detection. Expert Rev Mol Diagn. 2005;5(2):193–207.PubMedCrossRef
11.
Zurück zum Zitat Qureshi SS, Lewis SM, Gant VA, Treacher D, David BH, Brown KA. Increased distribution and expression of CD64 on blood polymorphonuclear cells from patients with systemic inflammatory response syndrome (SIRS). Clin Exp Immunol. 2001;125:258–65.PubMedCentralPubMedCrossRef Qureshi SS, Lewis SM, Gant VA, Treacher D, David BH, Brown KA. Increased distribution and expression of CD64 on blood polymorphonuclear cells from patients with systemic inflammatory response syndrome (SIRS). Clin Exp Immunol. 2001;125:258–65.PubMedCentralPubMedCrossRef
12.
Zurück zum Zitat Groselj-Grenc M, Ihan A, Derganc M. Neutrophil and monocyte CD64 and CD163 expression in critically ill neonates and children with sepsis: comparison of fluorescence intensities and calculated indexes. Mediators Inflamm. 2008. doi: 10.1155/2008/202646. Groselj-Grenc M, Ihan A, Derganc M. Neutrophil and monocyte CD64 and CD163 expression in critically ill neonates and children with sepsis: comparison of fluorescence intensities and calculated indexes. Mediators Inflamm. 2008. doi: 10.1155/2008/202646.
13.
Zurück zum Zitat Hirakata Y, Yanagihara K, Kurihara S, Izumikawa K, Seki M, Miyazaki Y, et al. Comparison of usefulness of plasma procalcitonin and C-reactive protein measurements for estimation of severity in adults with community-acquired pneumonia. Diagn Microbiol Infect Dis. 2008;61:170–4.PubMedCrossRef Hirakata Y, Yanagihara K, Kurihara S, Izumikawa K, Seki M, Miyazaki Y, et al. Comparison of usefulness of plasma procalcitonin and C-reactive protein measurements for estimation of severity in adults with community-acquired pneumonia. Diagn Microbiol Infect Dis. 2008;61:170–4.PubMedCrossRef
14.
Zurück zum Zitat Riedel S, Melendez JH, An AT, Rosenbaum JE, Zenilman JM. Procalcitonin as a marker for the detection of bacteremia and sepsis in the emergency department. Am J Clin Pathol. 2011;135(2):182–9.PubMedCrossRef Riedel S, Melendez JH, An AT, Rosenbaum JE, Zenilman JM. Procalcitonin as a marker for the detection of bacteremia and sepsis in the emergency department. Am J Clin Pathol. 2011;135(2):182–9.PubMedCrossRef
15.
16.
Zurück zum Zitat Jeschke MG, Finnerty CC, Kulp GA, Kraft R, Herndon DN. Can we use C-reactive protein levels to predict severe infection or sepsis in severely burned patients? Int J Burn Trauma. 2013;3(3):137–43. Jeschke MG, Finnerty CC, Kulp GA, Kraft R, Herndon DN. Can we use C-reactive protein levels to predict severe infection or sepsis in severely burned patients? Int J Burn Trauma. 2013;3(3):137–43.
17.
Zurück zum Zitat Chiwakata CB, Manegold C, Bonicke L, Waase I, Julch C, Dietrich M. Procalcitonin as a parameter of disease severity and risk of mortality in patients with Plasmodium falciparum malaria. J Infect Dis. 2001;183:1161–4.PubMedCrossRef Chiwakata CB, Manegold C, Bonicke L, Waase I, Julch C, Dietrich M. Procalcitonin as a parameter of disease severity and risk of mortality in patients with Plasmodium falciparum malaria. J Infect Dis. 2001;183:1161–4.PubMedCrossRef
18.
Zurück zum Zitat Koeze J, Hendrix MG, van den Bergh FA, Brouwer RM, Zijlstra JG. In critically ill patients the procalcitonin level can be misleading. Crit Care. 2011;15:422.PubMedCentralPubMedCrossRef Koeze J, Hendrix MG, van den Bergh FA, Brouwer RM, Zijlstra JG. In critically ill patients the procalcitonin level can be misleading. Crit Care. 2011;15:422.PubMedCentralPubMedCrossRef
19.
Zurück zum Zitat Au-Yong A. Towards evidence-based emergency medicine: best BETs from the Manchester Royal Infirmary. BET 2: C-reactive protein in the diagnosis of bacteraemia. Emerg Med J. 2012;29(5):423–4.PubMedCrossRef Au-Yong A. Towards evidence-based emergency medicine: best BETs from the Manchester Royal Infirmary. BET 2: C-reactive protein in the diagnosis of bacteraemia. Emerg Med J. 2012;29(5):423–4.PubMedCrossRef
20.
Zurück zum Zitat Jereb M, Lunaček NK, Kotar T, Saksida A, Petrovec M, Avšič-Županc T. Procalcitonin in hantavirus infections. Scand J Clin Lab Invest 2011;71(4):287–91.PubMedCrossRef Jereb M, Lunaček NK, Kotar T, Saksida A, Petrovec M, Avšič-Županc T. Procalcitonin in hantavirus infections. Scand J Clin Lab Invest 2011;71(4):287–91.PubMedCrossRef
21.
Zurück zum Zitat Endo S, Suzuki Y, Takahashi G, Shozushima T, Ishikura H, Murai A, et al. Usefulness of presepsin in the diagnosis of sepsis in a multicenter prospective study. J Infect Chemother. 2012;18:891–7.PubMedCrossRef Endo S, Suzuki Y, Takahashi G, Shozushima T, Ishikura H, Murai A, et al. Usefulness of presepsin in the diagnosis of sepsis in a multicenter prospective study. J Infect Chemother. 2012;18:891–7.PubMedCrossRef
22.
Zurück zum Zitat Kurihara T, Yanagida A, Yokoi H, Koyata A, Matsuya T, Ogawa J, et al. Evaluation of cardiac assays on a benchtop chemiluminescent enzyme immunoassay analyzer, PATHFAST. Anal Biochem. 2008;375(1):144–6.PubMedCrossRef Kurihara T, Yanagida A, Yokoi H, Koyata A, Matsuya T, Ogawa J, et al. Evaluation of cardiac assays on a benchtop chemiluminescent enzyme immunoassay analyzer, PATHFAST. Anal Biochem. 2008;375(1):144–6.PubMedCrossRef
23.
Zurück zum Zitat Spanuth E, Wilhelm J, Loppnow H, Ebelt H, Ivandic B, Werdan K. Diagnostic and prognostic value of presepsin (soluble CD14 subtype) in emergency patients with early sepsis using the new assay PATHFAST presepsin. IFCCWorldLab- EuroMedLab 2011, Berlin. Spanuth E, Wilhelm J, Loppnow H, Ebelt H, Ivandic B, Werdan K. Diagnostic and prognostic value of presepsin (soluble CD14 subtype) in emergency patients with early sepsis using the new assay PATHFAST presepsin. IFCCWorldLab- EuroMedLab 2011, Berlin.
24.
Zurück zum Zitat Skvarc M, Stubljar D, Rogina P, Kaasch AJ. Non-culture-based methods to diagnose bloodstream infection: Does it work? Eur J Microbiol Immunol. 2013;3(2):97–104. doi: 10.1556/EuJMI.3.2013.2.2. Skvarc M, Stubljar D, Rogina P, Kaasch AJ. Non-culture-based methods to diagnose bloodstream infection: Does it work? Eur J Microbiol Immunol. 2013;3(2):97–104. doi: 10.1556/EuJMI.3.2013.2.2.
25.
Zurück zum Zitat Cid J, Aguinaco R. Sánchez R, García-Pardo G, Llorente A. Neutrophil CD64 expression as marker of bacterial infection: a systematic review and meta-analysis. J Infect. 2010;60:313–9.PubMedCrossRef Cid J, Aguinaco R. Sánchez R, García-Pardo G, Llorente A. Neutrophil CD64 expression as marker of bacterial infection: a systematic review and meta-analysis. J Infect. 2010;60:313–9.PubMedCrossRef
26.
Zurück zum Zitat Ng PC, Li G, Chui KM, Chu WC, Li K, Wong RP, et al. Neutrophil CD64 is a sensitive diagnostic marker for early-onset neonatal infection. Pediatr Res. 2004;56(5):796–803.PubMedCrossRef Ng PC, Li G, Chui KM, Chu WC, Li K, Wong RP, et al. Neutrophil CD64 is a sensitive diagnostic marker for early-onset neonatal infection. Pediatr Res. 2004;56(5):796–803.PubMedCrossRef
27.
Zurück zum Zitat Simon L, Gauvin F, Amre DK, Saint-Louis P, Lacroix J. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis. 2004;39:206–17.PubMedCrossRef Simon L, Gauvin F, Amre DK, Saint-Louis P, Lacroix J. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis. 2004;39:206–17.PubMedCrossRef
28.
Zurück zum Zitat Adib M, Bakhshiani Z, Navaei F, Saheb Fosoul F, Fouladi S, Kazemzadeh H. Procalcitonin: a reliable marker for the diagnosis of neonatal sepsis. Iran J Basic Med Sci. 2012;15(2):777–82.PubMedCentralPubMed Adib M, Bakhshiani Z, Navaei F, Saheb Fosoul F, Fouladi S, Kazemzadeh H. Procalcitonin: a reliable marker for the diagnosis of neonatal sepsis. Iran J Basic Med Sci. 2012;15(2):777–82.PubMedCentralPubMed
29.
Zurück zum Zitat Kocabas E, Sarıkçıoglu A, Aksaray N, Seydaoglu G, Seyhun Y, Yaman A. Role of procalcitonin, C-reactive protein, interleukin-6, interleukin-8 and tumor necrosis factor-α in the diagnosis of neonatal sepsis. Turk J Pediatr 2007;49(1):7–20.PubMed Kocabas E, Sarıkçıoglu A, Aksaray N, Seydaoglu G, Seyhun Y, Yaman A. Role of procalcitonin, C-reactive protein, interleukin-6, interleukin-8 and tumor necrosis factor-α in the diagnosis of neonatal sepsis. Turk J Pediatr 2007;49(1):7–20.PubMed
30.
Zurück zum Zitat Azevedo JR, Torres OJ, Czeczko NG, Tuon FF, Nassif PA, Souza GD. Procalcitonin as a prognostic biomarker of severe sepsis and septic shock. Rev Col Bras Cir. 2012;39(6):456–60.PubMedCrossRef Azevedo JR, Torres OJ, Czeczko NG, Tuon FF, Nassif PA, Souza GD. Procalcitonin as a prognostic biomarker of severe sepsis and septic shock. Rev Col Bras Cir. 2012;39(6):456–60.PubMedCrossRef
31.
Zurück zum Zitat Sargentini V, Ceccarelli G, D’Alessandro M, Collepardo D, Morelli A, D'Egidio A, et al. Presepsin as a potential marker for bacterial infection relapse in critical care patients. A preliminary study. Clin Chem Lab Med 2014; doi:10.1515/cclm-2014-0119. [Epub ahead of print] Sargentini V, Ceccarelli G, D’Alessandro M, Collepardo D, Morelli A, D'Egidio A, et al. Presepsin as a potential marker for bacterial infection relapse in critical care patients. A preliminary study. Clin Chem Lab Med 2014; doi:10.1515/cclm-2014-0119. [Epub ahead of print]
32.
Zurück zum Zitat Shozushima T, Takahaski G, Matsumoto N, Kojika M, Okamura Y, Endo S. Usefulness of presepsin (sCD14-ST) measurements as a marker for the diagnosis and severity of sepsis that satisfied diagnostic criteria of systemic inflammatory response syndrome. J Infect Chemother. 2011;17:764–9.PubMedCrossRef Shozushima T, Takahaski G, Matsumoto N, Kojika M, Okamura Y, Endo S. Usefulness of presepsin (sCD14-ST) measurements as a marker for the diagnosis and severity of sepsis that satisfied diagnostic criteria of systemic inflammatory response syndrome. J Infect Chemother. 2011;17:764–9.PubMedCrossRef
33.
Zurück zum Zitat Yaegashi Y, Shirakawa K, Sato N, Suzuki Y, Kojika M, Imai S, et al. Evaluation of a newly identified soluble CD14 subtype as a marker for sepsis. J Infect Chemother. 2005;11(5):234–8.PubMedCrossRef Yaegashi Y, Shirakawa K, Sato N, Suzuki Y, Kojika M, Imai S, et al. Evaluation of a newly identified soluble CD14 subtype as a marker for sepsis. J Infect Chemother. 2005;11(5):234–8.PubMedCrossRef
34.
Zurück zum Zitat Ulla M, Pizzolato E, Lucciari M, Loiacono M, Soardo F, Forno D, et al. Diagnostic and prognostic value of presepsin in the management of sepsis in the emergency department: a multicentre prospective study. Crit Care. 2013;17:R168.PubMedCentralPubMedCrossRef Ulla M, Pizzolato E, Lucciari M, Loiacono M, Soardo F, Forno D, et al. Diagnostic and prognostic value of presepsin in the management of sepsis in the emergency department: a multicentre prospective study. Crit Care. 2013;17:R168.PubMedCentralPubMedCrossRef
35.
Zurück zum Zitat Palmiere C, Mussap M, Bardy D, Cibecchini F, Mangin P. Diagnostic value of soluble CD14 subtype (sCD14-ST) presepsin for the postmortem diagnosis of sepsis-related fatalities. Int J Legal Med. 2013;127:799–808.PubMedCrossRef Palmiere C, Mussap M, Bardy D, Cibecchini F, Mangin P. Diagnostic value of soluble CD14 subtype (sCD14-ST) presepsin for the postmortem diagnosis of sepsis-related fatalities. Int J Legal Med. 2013;127:799–808.PubMedCrossRef
36.
Zurück zum Zitat Liu B, Chen YX, Yin Q, Zhao YZ, Li CS. Diagnostic value and prognostic evaluation of Presepsin for sepsis in an emergency department. Crit Care. 2013;17(5):R244.PubMedCentralPubMedCrossRef Liu B, Chen YX, Yin Q, Zhao YZ, Li CS. Diagnostic value and prognostic evaluation of Presepsin for sepsis in an emergency department. Crit Care. 2013;17(5):R244.PubMedCentralPubMedCrossRef
37.
Zurück zum Zitat Romualdo LG, Torrella PE, González MV, Sánchez RJ, Holgado AH, Freire AO, et al. Diagnostic accuracy of presepsin (soluble CD14 subtype) for prediction of bacteremia in patients with systemic inflammatory response syndrome in the Emergency Department. Clin Biochem. 2014;47(7–8):505–8.PubMedCrossRef Romualdo LG, Torrella PE, González MV, Sánchez RJ, Holgado AH, Freire AO, et al. Diagnostic accuracy of presepsin (soluble CD14 subtype) for prediction of bacteremia in patients with systemic inflammatory response syndrome in the Emergency Department. Clin Biochem. 2014;47(7–8):505–8.PubMedCrossRef
38.
Zurück zum Zitat Oppegaard O, Skodvin B, Halse AK, Langeland N. CD64 as a potential biomarker in septic arthritis. BMC Infect Dis. 2013;19(13):278–85.CrossRef Oppegaard O, Skodvin B, Halse AK, Langeland N. CD64 as a potential biomarker in septic arthritis. BMC Infect Dis. 2013;19(13):278–85.CrossRef
39.
Zurück zum Zitat Wellinghausen N, Kochem AJ, Disqué C, Mühl H, Gebert S, Winter J, et al. Diagnosis of bacteremia in whole-blood samples by use of a commercial universal 16S rRNA gene-based PCR and sequence analysis. J Clin Microbiol. 2009;47(9):2759–65.PubMedCentralPubMedCrossRef Wellinghausen N, Kochem AJ, Disqué C, Mühl H, Gebert S, Winter J, et al. Diagnosis of bacteremia in whole-blood samples by use of a commercial universal 16S rRNA gene-based PCR and sequence analysis. J Clin Microbiol. 2009;47(9):2759–65.PubMedCentralPubMedCrossRef
Metadaten
Titel
Diagnostic and prognostic value of sCD14-ST—presepsin for patients admitted to hospital intensive care unit (ICU)
verfasst von
Matej Godnic
David Stubjar
Miha Skvarc
Tomislav Jukic
Publikationsdatum
01.07.2015
Verlag
Springer Vienna
Erschienen in
Wiener klinische Wochenschrift / Ausgabe 13-14/2015
Print ISSN: 0043-5325
Elektronische ISSN: 1613-7671
DOI
https://doi.org/10.1007/s00508-015-0719-5

Weitere Artikel der Ausgabe 13-14/2015

Wiener klinische Wochenschrift 13-14/2015 Zur Ausgabe

mitteilungen der gesellschaft

ÖGIM FLIP